Iterum Therapeutics plc Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Iterum Therapeutics plc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Iterum Therapeutics plc Return On Equity for the quarter ending June 30, 2024 was 566 %.
  • Iterum Therapeutics plc annual Return On Equity for 2023 was -664 %, a 472% decline from 2022.
  • Iterum Therapeutics plc annual Return On Equity for 2022 was -116 %, a 42.5% increase from 2021.
  • Iterum Therapeutics plc annual Return On Equity for 2021 was -202 %, a 291% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -664 -548 -472% Jan 1, 2023 Dec 31, 2023
2022 -116 +85.8 +42.5% Jan 1, 2022 Dec 31, 2022
2021 -202 -308 -291% Jan 1, 2021 Dec 31, 2021
2020 106 +986 Jan 1, 2020 Dec 31, 2020
2019 -880 -790 -882% Jan 1, 2019 Dec 31, 2019
2018 -89.6 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.